Tucaxen (Tucatinib), generic Tukysa is a prescription medicine used to treat locally advanced unresectable or metastatic HER2-positive breast cancer who have received at least one or more prior anti-HER2 treatment regimens. It is indicated in combination with trastuzumab and capecitabine medicine.